Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study

被引:10
作者
Iddawela, Mahesh [1 ,2 ,3 ,4 ,5 ,6 ]
Rueda, Oscar [1 ]
Eremin, Jenny [7 ,8 ]
Eremin, Oleg [7 ,8 ]
Cowley, Jed [9 ]
Earl, Helena M. [1 ,2 ,3 ,4 ]
Caldas, Carlos [1 ,2 ,3 ,4 ]
机构
[1] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England
[2] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Hills Rd, Cambridge, England
[3] Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England
[4] Cambridge Expt Canc Med Ctr, Cambridge, England
[5] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia
[6] Monash Univ, Sch Clin Sci, Clayton, Vic, Australia
[7] Lincoln Cty Hosp, Lincoln Breast Unit, Res & Dev, Lincoln, England
[8] Univ Nottingham, Nottingham Digest Dis Ctr, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham, England
[9] Lincoln Cty Hosp, PathLinks, Lincoln, England
关键词
Gene Expression; Copy Number; FFPE; Genomics; Breast Cancer; DASL; Molecular Inversion Probes Assay; Oncoscan Array; Molecular Markers; COMPARATIVE GENOMIC HYBRIDIZATION; MOLECULAR CHARACTERIZATION; PROSTATE-CANCER; FFPE SAMPLES; TUMOR-TISSUE; BEAD ARRAYS; NECK-CANCER; ASSAY; PATTERNS; MICROARRAYS;
D O I
10.1186/s12864-017-3867-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: An absence of reliable molecular markers has hampered individualised breast cancer treatments, and a major limitation for translational research is the lack of fresh tissue. There are, however, abundant banks of formalinfixed paraffin-embedded (FFPE) tissue. This study evaluated two platforms available for the analysis of DNA copy number and gene expression using FFPE samples. Methods: The cDNA-mediated annealing, selection, extension, and ligation assay (DASL T) has been developed for gene expression analysis and the Molecular Inversion Probes assay (Oncoscan T), were used for copy number analysis using FFPE tissues. Gene expression and copy number were evaluated in core-biopsy samples from patients with breast cancer undergoing neoadjuvant chemotherapy (NAC). Results: Forty-three core-biopsies were evaluated and characteristic copy number changes in breast cancers, gains in 1q, 8q, 11q, 17q and 20q and losses in 6q, 8p, 13q and 16q, were confirmed. Regions that frequently exhibited gains in tumours showing a pathological complete response (pCR) to NAC were 1q (55%), 8q (40%) and 17q (40%), whereas 11q11 (37%) gain was the most frequent change in non-pCR tumours. Gains associated with poor survival were 11q13 (62%), 8q24 (54%) and 20q (47%). Gene expression assessed by DASL correlated with immunohistochemistry (IHC) analysis for oestrogen receptor (ER) [area under the curve (AUC) = 0.95], progesterone receptor (PR)(AUC = 0.90) and human epidermal growth factor type-2 receptor (HER-2) (AUC = 0.96). Differential expression analysis between ER+ and ER-cancers identified over-expression of TTF1, LAF-4 and C-MYB (p <= 0.05), and between pCR vs non-pCRs, over-expression of CXCL9, AREG, B-MYB and under-expression of ABCG2. Conclusion: This study was an integrative analysis of copy number and gene expression using FFPE core biopsies and showed that molecular marker data from FFPE tissues were consistent with those in previous studies using fresh-frozen samples. FFPE tissue can provide reliable information and will be a useful tool in molecular marker studies.
引用
收藏
页数:13
相关论文
共 62 条
[1]   Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform [J].
Abramovitz, M. ;
Barwick, B. G. ;
Willis, S. ;
Young, B. ;
Catzavelos, C. ;
Li, Z. ;
Kodani, M. ;
Tang, W. ;
Bouzyk, M. ;
Moreno, C. S. ;
Leyland-Jones, B. .
BRITISH JOURNAL OF CANCER, 2011, 105 (10) :1574-1581
[2]   Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array [J].
Andre, Fabrice ;
Job, Bastien ;
Dessen, Philippe ;
Tordai, Attila ;
Michiels, Stefan ;
Liedtke, Cornelia ;
Richon, Catherine ;
Yan, Kai ;
Wang, Bailang ;
Vassal, Gilles ;
Delaloge, Suzette ;
Hortobagyi, Gabriel N. ;
Symmans, W. Fraser ;
Lazar, Vladimir ;
Pusztai, Lajos .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :441-451
[3]   Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break? [J].
Attard, Gerhardt ;
Cooper, Colin S. ;
de Bono, Johann S. .
CANCER CELL, 2009, 16 (06) :458-462
[4]   Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database [J].
Bagatell, Rochelle ;
Beck-Popovic, Maja ;
London, Wendy B. ;
Zhang, Yang ;
Pearson, Andrew D. J. ;
Matthay, Katherine K. ;
Monclair, Tom ;
Ambros, Peter F. ;
Cohn, Susan L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (03) :365-370
[5]   Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms [J].
Barnes, M ;
Freudenberg, J ;
Thompson, S ;
Aronow, B ;
Pavlidis, P .
NUCLEIC ACIDS RESEARCH, 2005, 33 (18) :5914-5923
[6]   Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays [J].
Bibikova, M ;
Talantov, D ;
Chudin, E ;
Yeakley, JM ;
Chen, J ;
Doucet, D ;
Wickham, E ;
Atkins, D ;
Barker, D ;
Chee, M ;
Wang, YX ;
Fan, JB .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (05) :1799-1807
[7]   Expression signatures that correlated with Gleason score and relapse in prostate cancer [J].
Bibikova, Marina ;
Chudin, Eugene ;
Arsanjani, Amir ;
Zhou, Lixin ;
Garcia, Eliza Wickham ;
Modder, Joshua ;
Kostelec, Monica ;
Barker, David ;
Downs, Tracy ;
Fan, Jian-Bing ;
Wang-Rodriguez, Jessica .
GENOMICS, 2007, 89 (06) :666-672
[8]  
Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11
[9]   Targeting EGFR in head and neck cancer: a decade of progress [J].
Boshoff, Chris ;
Posner, Marshall .
NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (03) :123-123
[10]   Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? [J].
Brenton, JD ;
Carey, LA ;
Ahmed, AA ;
Caldas, C .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) :7350-7360